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Objective: The objectives of this study were to explore the needs of patients with rheumatoid 
arthritis (RA) regarding support for medication use and to gain insight into their perspective 
on the suitability of eHealth technologies to address these needs.
Methods: Three focus groups were conducted with 28 patients with RA. Audio recordings made 
during the focus groups were transcribed verbatim. Two researchers independently performed 
an inductive, thematic analysis on the data (ie, the transcripts and field notes).
Results: The following three themes that described support needs of patients with RA for 
medication use were identified in the data: 1) informational support; 2) practical support; and 
3) emotional support. Informational support reflected the provision of information and facts, 
including advice, suggestions, and feedback from health care providers. Practical support 
included the reinforcement of practical skills as well as the provision of medication aids and phar-
macy services. Emotional support reflected a trusted patient–health care provider relationship, 
characterized by good communication. Although potential advantages of eHealth technologies 
to address the patients’ support needs were recognized, concerns over matters such as personal 
interaction with health care providers, privacy and data security, and the quality and reliability 
of online information were prevalent.
Conclusion: Patients with RA have informational, practical, and emotional support needs 
for medication use. Informational support seems to be most important. From the patients’ per-
spective, eHealth technologies may have the potential to address these needs. However, these 
technologies are regarded as a complement to, rather than a replacement of, current practices.
Keywords: qualitative research, rheumatology, information needs, practical needs, emotional 
needs
Introduction
Rheumatoid arthritis (RA) is a chronic, autoimmune disease that is characterized 
by inflammation of the joints, causing pain, swelling, and stiffness. If left untreated, 
RA can cause irreversible damage to the affected joints with resultant deformity and 
disability.1,2 It can also spread to other parts of the body.1–3 The treatment goal is 
clinical remission or at least low disease activity.4 Treatment consists primarily of 
pharmacotherapy or, more specifically, the use of disease-modifying antirheumatic 
drugs (DMARDs).4,5 Both synthetic and biologic DMARDs (bDMARDs) have proven 
to be clinically effective in treating RA.6,7
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However, patients with RA encounter various problems 
with their medication. These problems hinder the effectiveness 
of treatment and have deleterious clinical consequences.8,9 
Previous studies have identified various problems. For 
example, 54% of patients have inadequate knowledge of 
methotrexate therapy, which may result in incorrect usage,10 
and 47% have concerns regarding potential adverse conse-
quences of their medication prescriptions.11 Twenty percent 
are unable to open the pharmaceutical packages.12 Overall, 
30%–80% of DMARD users do not take their medication 
as prescribed.13 The foregoing implies that current practices 
do not ensure safe and effective medication use.
Additional support might prevent or fix the problems that 
patients with RA encounter with their medication. Morgan 
et al,14 for example, indicated that higher perceived support 
from health care providers such as addressing treatment 
beliefs may improve adherence to adalimumab. Knowledge 
about patients’ support needs is therefore indispensable.15,16 
In the light of patient-centered care, which places patients at 
the center of the health care system, their perspective should 
be taken into account.17 So far, no studies have explored the 
support needs of patients with RA for medication use from 
their own perspective.
Although patients with RA visit health care providers 
only a few times a year, they deal with their medication 
on a daily basis. Ongoing support is therefore preferable.18 
Additional support could potentially be provided by eHealth, 
a term defined by the World Health Organization (WHO) as 
the use of information and communication technologies for 
health.19 eHealth technologies have the potential of support-
ing patients independent of place and time.20 However, it 
remains largely unknown if, or to what extent, patients with 
RA perceive a need for eHealth technologies and which pre-
conditions should be met in order to implement and use them 
successfully. Therefore, the objectives of this study were to 
explore the needs of patients with RA regarding support for 
medication use and to gain insight into their perspective on 
the suitability of eHealth technologies to address these needs. 
To our knowledge, this is the first study approaching these 
objectives from the point of view of patients themselves.
Methods
study design
A descriptive, exploratory design was used – thus, this 
study did not rely on a preexisting theoretical framework. 
Focus groups were conducted because this method of data 
collection is likely to yield the most valuable information in 
exploratory studies.21 Indeed, the group interaction enriched 
the quantity and quality of the information gathered.22
Two patients with RA (Herman van Duijn [HvD] and 
Peter van Grinsven [PvG]) were involved in this study as 
patient research partners. During the first contact meeting, 
mutual goals and expectations were discussed and these 
patients agreed that they would fulfill a consulting and 
advising role in all study phases.
Patient recruitment
A convenience sample was recruited from the Department 
of Pharmacy at the Sint Maartenskliniek, Nijmegen, the 
Netherlands. One of the researchers (BJFvdB), a certified clini-
cal pharmacist at the Department of Pharmacy, had access to 
the register and was legally authorized as pharmacist to view 
the patients’ hospital records, which were used to identify 
eligible patients. Eligibility criteria were as follows: 1) clinical 
diagnosis of RA; 2) current use of at least one DMARD; 3) age 
$18 years; and 4) proficiency in the Dutch language. Eligible 
patients who received their medication at the Department of 
Pharmacy between January and April 2016 were sent an invita-
tion by post to participate. Guided by previous experiences with 
this recruitment technique (ie, impersonal invitations to focus 
groups on predetermined dates and times), showing response 
rates of 10%–20%, 250 patients were invited. An incentive for 
participation was offered in the form of a 25 Euro gift card.
Data collection
The focus groups were conducted in a quiet, comfortable room 
at the Sint Maartenskliniek. An independent, experienced 
moderator (Annette Heijnen [AH] or Maaike Abrahamse 
[MA]) and an assistant moderator (EGEM or Ellen Selten 
[ES]) facilitated the focus groups. A discussion guide was used 
to standardize and structure the data collection (Figure 1).
The discussion guide was developed in collaboration 
with the patient research partners and informed by a review 
of relevant literature.23–25 The moderator started with an 
engagement question and progressed to questions specific to 
the objectives of this study (ie, exploratory questions). The 
focus groups ended with an exit question.26 The discussions 
were audio recorded, and the audio recordings were subse-
quently transcribed verbatim by a professional transcription 
service. The assistant moderator did not actively take part 
in the discussions but monitored nonverbal behavior as well 
as linguistic and atmospheric elements and recorded these 
observations in field notes. After each focus group, the field 
notes were expanded into rich descriptions of these observa-
tions. The field notes were complementary to the transcripts 
since the latter did not reflect the entire atmosphere of the 
discussions. The field notes were used to aid in interpreting 
the findings.
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Prior to the focus groups, each patient completed a brief 
questionnaire with demographic and clinical variables, 
including gender, date of birth, marital status, living status, 
level of education, employment status, disease duration, and 
current medication use.
Data analysis
An inductive, thematic analysis was applied to the transcripts 
and field notes. The six phases of thematic analysis were 
followed in an iterative manner by constantly moving back 
and forth between them. This comprised becoming famil-
iarized with the data, generating initial codes, searching for 
themes, reviewing themes, defining and naming themes, 
and writing up the results.27 To ensure the trustworthiness 
of the data analysis, two researchers (EGEM and BJFvdB) 
independently analyzed the data.28 Discrepancies were 
resolved through discussion and consensus or referral to 
a third researcher (JEV). Memos were written to help the 
researchers keep track of decisions made during analysis 
of the data.28 The occurrence of data saturation was investi-
gated. The number of focus groups was considered sufficient 
when the analysis of the last focus group did not result in the 
identification of new themes. The software program MAX-
QDA 10 was used to analyze the data. Additionally, a mem-
ber check was conducted. For each focus group, a summary 
of the discussions was sent to the patients who participated 
in that particular group. They were asked to comment on its 
factual and interpretative accuracy, and adjustments were 
made accordingly. Some relevant quotes of the patients were 
selected to support the findings. The quotes were translated 
from Dutch to English by a certified translation bureau.
ethical considerations
The Medical Research Ethical Committee of Arnhem-
Nijmegen, the Netherlands, waived ethical approval since the 
medical research involving human subjects act did not apply 
to this study (file number: 2016-2464). All patients gave 
written informed consent for participation. Patient data were 
handled according to the applicable laws and regulations (eg, 
the Dutch Data Protection Act). Personal identifying informa-
tion was replaced by study codes. A document that linked 
the study codes to the patients’ identifying information was 
digitally stored and protected. Only the researchers directly 
involved in this study had access to the document.
Results
A total of 28 (11%) eligible patients responded to the invita-
tion. They participated in three focus groups that were con-
ducted in May 2016. The discussions lasted between 100 and 
150 minutes. The patient characteristics are shown in Table 1.
The results were described in two separate parts. The 
following three overarching themes were identified in 
relation to support needs for medication use (objective 1): 
1) informational support; 2) practical support; and 3) emo-
tional support. The following three overarching themes were 
identified in relation to the suitability of eHealth technologies 
(objective 2): 1) previous experiences; 2) perceived advan-
tages and disadvantages; and 3) preconditions for use.
Part 1: support needs for medication use
informational support
Informational support reflected the provision of information 
and facts, including advice, suggestions, and feedback from 
Engagement questions
–  Could you tell us something about yourself? For example, 
what medication do you currently use to treat your RA?
This question was asked to the patients in a round robin fashion.
Exploratory questions
Part 1: support needs for medication use
–  Think about the problems that you encounter with your 
medication. Write down what comes to your mind.
The patients could individually write down their answers on a 
blank piece of paper that was provided prior to the start of the 
focus group.
– What did you write down?
This question was asked to the patients in a round robin fashion. 
All answers were written on a flip chart by the assistant moderator.
– Take a look at the flip chart. Do you miss anything?
– What problems are most important to you? Pick three from the 
flip chart and explain the motivations behind your choices.
This question was asked to the patients in a round robin fashion.
– What can be done to prevent or fix these problems?
– How do you experience the support for medication use that is 
currently provided?
• Which of your support needs are already addressed?
• Which of your support needs are still unmet?
Part 2: the suitability of eHealth technologies
– What eHealth technologies do you know?
This question was asked to the patients in a round robin fashion.
– What are, in your opinion, advantages and disadvantages of 
eHealth technologies?
– Which preconditions should be met in order for you to use 
eHealth technologies?
– Think about your support needs for medication use. Could 
eHealth technologies be suitable to address these needs?
Exit questions
– Is there anything else you would like to share with us? 
Figure 1 Discussion guide.
Abbreviation: rA, rheumatoid arthritis.
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health care providers. This overarching theme comprised two 
interrelated subthemes: unambiguous, high-quality informa-
tion and more information.
Unambiguous, high-quality information
The patients highly valued being provided with information 
about their medication. For most patients, this was the first 
thing they mentioned during the focus groups. They sought 
information from a variety of sources, both written and 
oral. Although general, written information was considered 
valuable, the patients preferred health care providers who 
provided them oral information directly, tailored to their 
personal situation.
That they (healthcare providers) really give you the informa-
tion they know. And that they also give you tips on what 
you have to watch out for. [Female, 49 years]
Some patients mentioned that, when seeking information, 
they encountered conflicting information between different 
information sources.
They say: ‘You always have to ask everything here (in the 
hospital).’ That’s what I do, but sometimes you also search 
for information yourself. Then you do sometimes see that 
there’s a difference in side effects, the way you have to 
administer it … So, it’s different to the information leaflets 
or what you read in the brochures. [Female, 49 years]
This resulted in ambiguity and uncertainty. In such cases, 
the patients preferred contacting their health care providers 
directly. Health care providers could best deal with these 
uncertainties by giving advice, suggestions, and feedback.
That’s what’s good about my rheumatologist. He says: ‘Get 
in touch … what are we going to do …’ […] And having 
that discussion is great. That you just get confirmation. 
[Female, 68 years]
However, some patients also mentioned that they received 
conflicting information from different health care providers. 
It was stated that health care providers, especially the ones 
not specialized in rheumatology, needed to be better able to 
provide unambiguous, high-quality information about the 
patients’ medication.
More information
Most patients expressed a need to receive more information 
than currently provided, in particular about side effects, 
drug–drug interactions, and long-term consequences of 
medication use. Some patients mentioned that they had 
difficulties in distinguishing between the side effects and 
symptoms caused by RA.
Sometimes you don’t properly know if it’s because of the 
medication, or if you are having a flare. […] So, what’s the 
cause? [Female, 58 years]
Table 1 characteristics of the patients
Characteristics Total (n=28) Group 1 (n=11) Group 2 (n=9) Group 3 (n=8)
gender (%)
Male 32 45 22 25
Female 68 55 78 75 
Age (years), median (range) 67.5 (49–80) 56 (49–79) 69 (59–80) 69 (59–78)
Married or cohabiting (%) 75 82 56 88
level of educationa (%) 
low 39 18 67 38
Medium 18 36 0 12
high 43 46 33 50
employment status (%)
employed 18 46 0 0
Unemployed 82 54 100 100
Disease duration (years), median (range) 16.5 (5–42) 18 (8–42) 13 (6–40) 20 (5–41)
Medication use (%)
synthetic DMArD, methotrexate 54 45 78 38
synthetic DMArD, other 29 9 44 38
Biologic DMArD, anti-TnF 64 91 33 63
Biologic DMArD, others 11 9 11 13
corticosteroid 4 0 0 13
number of DMArDs $2 (%) 61 55 67 63
Note: alevel of education: low = up to and including lower technical and vocational training, medium = up to and including secondary technical and vocational training, and 
high = up to and including higher vocational training and university.
Abbreviations: DMArDs, disease-modifying antirheumatic drugs; TnF, tumor necrosis factor.
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Consequently, they were unsure when it would be appro-
priate to seek medical advice.
Yes, because then I think: Okay, am I going too quickly? 
Because, maybe, tomorrow will be fine. [Female, 49 years]
The patients said that receiving more information 
about side effects and drug–drug interactions, no matter 
how rare, could help them to feel more in control and seek 
medical advice when appropriate. Concerning long-term 
consequences of medication use, there was a need for more 
information about bDMARDs. This was attributed to the 
fact that bDMARDs have been in clinical use for a relatively 
short time. Thus, long-term data on safety are still lacking 
and this can evoke concerns in some patients.
Research is still ongoing of course, to the side effects of 
biologicals. And of course that takes time, because these 
things haven’t been around very long … So I think that’s 
important. Which doesn’t mean that I won’t use them any-
more once I know the results. Without those things I just 
can’t function. I can understand that. But I still think it’s 
important, as there are a lot of side effects that people don’t 
know about at all. It makes you think: Hey, can it have that 
effect on me as well? [Female, 59 years]
Practical support
Practical support included the reinforcement of practical 
skills as well as the provision of medication aids and phar-
macy services. Three subthemes within this overarching 
theme were as follows: help with practical problems, moni-
toring of self-administration, and goods and services.
help with practical problems
Some patients mentioned that they experienced practical 
problems. First, they struggled to remove the tablets or 
capsules from the pharmacy blister packs.
Those packages … I just don’t understand it. They’re 
developed for patients with arthritis. And they’re shut so 
tightly, we just can’t get them open. Really great. […] It’s 
just a way of keeping us busy. [Female, 61 years]
To overcome this problem, some patients used scissors. 
However, they preferred the pharmacy assistant to remove 
the tablets or capsules from the packs and put them in a 
container. The self-administration of subcutaneous injections 
could also cause problems. One patient said that unscrewing 
the syringe caps and pressing the syringes was difficult for 
her because she lacked strength in her hands.
I also have a prosthesis here, which makes it a little difficult 
to inject. Then you have to … The strength to, to unscrew 
the syringe caps … especially in the beginning they were 
screwed too tight. They could hardly be unscrewed. So that 
was a problem. [Female, 69 years]
Furthermore, most patients who self-administered their 
medication via subcutaneous injections suffered from side 
effects at the injection site, such as pain, rash, redness, 
bruises, and swelling. Although the patients usually learned 
by experience how to alleviate the side effects, they would 
prefer to be provided with more tips and tricks on how to 
deal with these side effects.
Well, of course I was given information on how to self-
administer the injections. It’s just that loads of things 
weren’t said at the time. [Female, 79 years]
Monitoring of self-administration
Also, there was a need for regular monitoring of the self- 
administration process. The patients would feel more confi-
dent if they knew that they were still doing it correctly.
goods and services
The provision of medication aids, such as dispensers, tablet 
splitters, sharp containers, cooler bags, and reminders, was 
highly valued by the patients. Nevertheless, some patients 
said that the storage and transport of their medication was 
problematic, especially under circumstances such as going 
on holiday.
As I am going on a holiday … And then it is quite a fuss 
to take it (the medication) with me on the airplane. That 
cooler bag takes up space, and if you’re only allowed to 
take your cabin baggage, that means a lot of inching and 
pinching. [Male, 70 years]
In general, the patients felt that the pharmacy sufficiently 
supported them regarding medication use. Services they 
appreciated were, for example, the offering of help, the 
alerts when their medication was running out, and the home 
delivery of medication on a date and time of their choosing.
emotional support
Emotional support reflected a trusted patient–health care 
provider relationship, characterized by good communica-
tion. This overarching theme comprised the following three 
interrelated subthemes: openness, active listening, and 
collaboration.
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Openness
A trusted patient–health care provider relationship, character-
ized by good communication, was important to the patients. 
They expressed a need to feel at ease to communicate openly. 
One patient mentioned that she highly valued the openness 
she had with her rheumatologist.
For 25 years, I had such a nice rheumatologist. I could say 
everything to him. And he said everything to me. [Female, 
67 years]
Active listening
Another important part of good communication was active 
listening. The patients mentioned that health care providers 
could pay more attention to, for example, their concerns 
regarding side effects. They could do this by taking enough 
time to listen and respond to the patients. According to some 
patients’ experience, health care providers do not always take 
enough time to do this.
Then some woman asks you questions about your well-
being. The rheumatologist doesn’t have time for that 
anymore. [Female, 79 years]
Above all, the patients wanted health care providers to 
take them seriously.
I think that’s the very worst … In the pharmacy … They 
act as if I’m stupid. When I say it (the medication) doesn’t 
work, they say: ‘That’s not true.’ […] You’re called a liar! 
[Female, 61 years]
collaboration
Most patients preferred to use as little medication as possible. 
They valued tapering of their medication and adjusting doses 
in consultation with the rheumatologist. Some patients had 
a need for a flexible medication regimen that allowed them 
to self-adjust doses.
I also tried it every other week, but then I got the flu. She 
(the rheumatologist) said: ‘Just start taking it once a week 
and then extend it again.’ I think that’s really good, that 
I can just try things out for myself. That’s really important 
for me. [Female, 55 years]
Having control over their medication use could help the 
patients to fit this activity into their daily lives in the best 
possible way. However, close collaboration with the rheu-
matologist was considered important in this.
I can easily contact my rheumatologist. That works for me. 
Then we can have a discussion about what to do. [Female, 
55 years].
Correspondingly, the patients preferred it when health 
care providers involved them in decision-making about their 
treatment. The extent to which they preferred to be involved 
differed for each individual.
Part 2: the suitability of ehealth 
technologies
Previous experiences
Only a few patients were familiar with the term eHealth. 
After explaining the WHO’s definition of the term, it turned 
out that almost all patients had used some form of an eHealth 
technology at least once. In particular, the patients had 
frequently searched the Internet to obtain information about 
their medication.
I use Google. Every now and then I look it up. If I get any-
thing new, like: What is it? And what are the side effects? 
[Female, 59 years]
They also made use of eHealth technologies by ordering 
medication online, consulting health care providers by email, 
and connecting with other patients via online communities. 
These forms were, however, used infrequently and only by 
a few patients.
Perceived advantages and disadvantages
Most patients believed that they could benefit from eHealth 
in some way. They thought that it could complement current 
practices. However, the awareness of its advantages was low. 
The patients mentioned that eHealth technologies could have 
the advantages of being less time-consuming, as compared 
to hospital visits, and easily accessible.
It would be easy for once. That you can just send a quick email 
with your question and have an answer the next morning.  
[…] Well, yes, then you don’t need to go for check-ups 
anymore. [Male, 77 years]
The patients had several concerns regarding eHealth 
technologies. Some patients were concerned that eHealth 
technologies would contribute to impersonal care by replac-
ing face-to-face interactions with health care providers. 
Traditional, real-life visits were still preferred by most 
patients, and they emphasized that these should never be 
replaced by eHealth technologies.
That’s the danger. You do need to keep your eye on it 
and make sure that there’s still personal contact. [Female, 
49 years]
One patient also mentioned that it would be difficult for 
him to express himself by typing instead of speaking when 
using an eHealth technology such as email consultation. 
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Other patients added that in particular patients belonging to 
the “older generation” could experience difficulties with this 
form of communication as they are just not used to it.
No, there’s nothing better than having someone on the 
other side of the desk who you can just ask questions. 
Because otherwise we’re just one tiny step away from you 
being the robot and I being the patient. […] No, as far as 
I’m concerned, it shouldn’t have to go that far. [Female, 
64 years]
Also, the patients expressed concerns about matters such 
as privacy and data security. This was partially based on 
noted media reports about data leakage.
We’re actually already being spied on by everyone, because 
if you’ve got a phone like this (smartphone), then it’s not 
a secret for anyone. You don’t have any privacy then. 
[Female, 61 years]
The quality and reliability of information they obtained 
from the Internet was also a point of concern for the patients. 
This was especially the case when the source of this online 
information was unclear, and commercial interests may 
possibly be involved.
Preconditions for use
The patients mentioned several preconditions for the use 
of eHealth technologies. These preconditions were mostly 
related to the previously described concerns. Some patients 
said that they were not interested in using eHealth technolo-
gies at all. A reason for their lack of interest was that they 
considered themselves unable to use modern, electronic 
technologies such as computers, smartphones, and the 
Internet. They also believed that they were already provided 
with sufficient support regarding medication use, making 
it of little interest to use eHealth technologies. However, 
they were concerned that, due to the rapid development of 
modern, electronic technologies, they would be forced to use 
them. It was stated that eHealth technologies should never be 
mandatory and that patients should always have the choice 
whether to use them or not.
It’s making it mandatory. People just don’t want that. 
[Female, 59 years]
The ease of use was mentioned as an important precondi-
tion. According to one patient, using an eHealth technology 
should require as few actions as possible.
Well, if I talk and that thing just works, yes. No. But if 
I just speak and I say: ‘Start up, do this, do that …’ [Female, 
61 years]
Assuring privacy and data security were also mentioned 
here. Furthermore, when it comes to online information, the 
patients found it important that they could obtain information 
about their medication from trusted sources.
I can imagine if this (information about medication on the 
Internet) all falls under the responsibility of the hospital … 
And I know, if I’m logged in and search for something, that 
all the information I get is reliable … [Female, 56 years]
Discussion
This is the first study to document the needs of patients with 
RA regarding support for medication use from their own 
perspective. The provision of unambiguous, high-quality 
information was the most important need expressed by the 
patients. They preferred receiving oral information, tailored 
to their personal situation, directly from health care pro-
viders. Besides informational support needs, a variety of 
practical (eg, the provision of medication aids and pharmacy 
services) and emotional (eg, a trusted patient–health care 
provider relationship) support needs were identified. The 
identification of the themes – informational, practical, and 
emotional support – corresponds to the three types of support 
distinguished by Schaefer et al.29 The distinction of these 
support types is widely used in research on social support. 
The findings of this study suggest that, next to friends and 
family members, health care providers could also provide 
these types of support. This is supported by the studies of 
Garwick et al,30 Warwick et al,31 and Masters et al.32 These 
researchers also identified health care providers as a source 
of informational as well as practical and social support. 
Although potential advantages of eHealth technologies to 
address the patients’ support needs were recognized, con-
cerns over matters such as personal interaction with health 
care providers, privacy and data security, and the quality and 
reliability of online information were prevalent.
We found that, above all, the patients had a need for 
unambiguous, high-quality information about their medica-
tion. They sought information from a variety of sources and 
mentioned that they encountered conflicting information 
between different sources, including health care providers. 
Conflicting information is a point of concern because it 
is associated with nonadherence and medication-related 
anxiety.33–35 As the amount of information available to 
patients increases, especially as a result of more and more 
health-related websites, this problem has increased. More-
over, research has shown that online information targeted 
at patients with RA varies widely in terms of its quality.36,37 
Therefore, it may be desirable for health care providers to 
direct patients with RA to carefully screened websites with 
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high-quality information as a part of routine patient educa-
tion and counseling. Furthermore, to ensure better alignment, 
health care providers may want to consider who provides 
what information.
This study showed that the need for informational support 
is constant and variable. The patients did not only have a need 
for information at the start of their medication but during the 
entire duration of usage, as concerns emerged. Thus, needs 
varied over time. Regular monitoring of a patient’s informa-
tional support requirements is therefore warranted.38 Most 
patients expressed a need for more information about their 
medication than is currently provided. Detailed information 
about side effects, drug–drug interactions, and long-term 
consequences of medication use was preferred. However, 
another important finding of this study was that each 
patient needed a different amount of information. Previous 
studies of patients with RA have documented an association 
between the need for more information and being a woman, 
being younger, and having a longer disease duration.39–43 
Regarding medication use, only one study has shown that, in 
men, using more DMARDs and suffering from side effects 
are associated with a need for more information.42 This sup-
ports the notion that the provision of information should be 
tailored to an individual’s personal situation.38 
The patients preferred increased support regarding the 
self-administration of subcutaneous injections and regu-
lar monitoring of this process. Patients are provided with 
information leaflets and step-by-step guides to correctly 
self-administer subcutaneous injections. In our hospital, they 
are also trained by the rheumatology nurse or the pharmacy 
assistant in self-administering their medication via subcuta-
neous injections until competency is achieved. However, we 
found that in time, patients may become uncertain about their 
competency. Creating an opportunity for patients to refresh 
their knowledge and practical skills once in a while may be 
desirable in order for them to self-administer subcutaneous 
injections with confidence.
The patients valued a trusted patient–health care provider 
relationship. Above all, they wanted to be taken seriously. 
Research has shown that, for the development of trust, the 
patients’ feeling of being taken seriously is a prerequisite.44–46 
Moreover, good communication between patients and health 
care providers may bring numerous benefits, including better 
adherence rates.47–49 A meta-analysis has shown that good 
communication is highly correlated with better adherence 
rates. There is a 19% higher risk of nonadherence among 
patients whose health care providers communicate poorly.47 
Therefore, a trusted patient–health care provider relationship, 
characterized by good communication, is pivotal in pursing 
adherence. This makes it worthwhile for health care providers 
to keep investing in the development of good communica-
tion skills.
Potential advantages of eHealth technologies to address the 
patients’ support needs for medication use were recognized. 
Although most patients believed that they could benefit from 
eHealth in some way, they still had concerns. This finding is 
in line with previous studies that described chronic disease 
patients’ concerns regarding a changing patient–health care 
provider relationship, involving less personal interaction.50,51 
It suggests that the use of eHealth technologies has to comple-
ment current practices rather than replacing them. One pos-
sible solution is provided by a blended care model, in which a 
combination of face-to-face interactions between patients and 
health care providers are coupled with information provided 
by the way of eHealth technologies. There already has been 
some experience with this new form of health care in other 
chronic diseases.52–54 Although it is seen as a promising strat-
egy, the actual use of blended care in practice is disappointing. 
Moreover, evidence regarding its feasibility and acceptability 
in the treatment of RA is lacking. Given this information, we 
suggest that future research should explore the possibilities 
of blended care in the treatment of RA.
Other concerns over matters such as privacy and data 
security and the quality and reliability of online information 
are also described in the literature.50,51,55,56 In order to improve 
the adoption of eHealth technologies by patients with RA, 
addressing their concerns should be a priority. This may be 
accomplished by providing them with detailed information 
regarding their points of concern. Also, it has to make sure 
that all preconditions for use are met.
The biggest strength of this study is that it shed light on 
the point of view of patients themselves. Their perspective 
still remains too much in the background in contemporary 
research. No other studies have explored the needs of patients 
with RA regarding support for medication use from their own 
perspective. Therefore, this study contributes to filling to the 
aforementioned gap of knowledge. Another strength is the 
involvement of two patient research partners. Their additional 
insights gave, among others, credibility to the findings. The 
methods used during the data analysis, such as investigating 
the occurrence of data saturation, analyzing the data indepen-
dently by two researchers (ie, researcher triangulation), and 
conducting a member check, are also considered strengths as 
they enhanced this study’s quality. However, some limitations 
also need to be addressed. Two hundred and fifty patients 
were invited to participate in the focus groups, but 222 (89%) 
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
14
9 
on
 0
9-
Ap
r-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence 2018:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
357
support needs for medication use and the suitability of ehealth technologies
patients did not respond to the invitation. The reasons for 
not responding are unknown. As focus groups are usually 
made up of a very small number of patients who voluntarily 
participate, it cannot be assumed that the patients who 
participated in the focus groups are representative of a ran-
dom sample of the total patient population. Moreover, mostly 
older patients with a longer disease duration participated. 
The fact that the findings are limited to patients with these 
characteristics cannot be ignored. It should be noted that the 
interest in eHealth technologies varies with age.57 The lack 
of the perspective of younger patients may therefore have 
implications for the findings.
Conclusion
We found that patients with RA have informational, practical, 
and emotional support needs for medication use. Informa-
tional support seems to be most important. From the patients’ 
perspective, eHealth technologies may have the potential 
to address these needs. However, these technologies are 
regarded as a complement to, rather than a replacement of, 
current practices.
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